[language-switcher]
Walaa Omar AlBenayan is a Saudi healthcare leader and pharmaceutical scientist with a career spanning academia and the biopharmaceutical industry. She pursued advanced training in the United States, earning a Master’s and PhD in Pharmaceutical Sciences and Drug Design, followed by postdoctoral research in Experimental Medicine KAIMRC and an academic appointment at Alfaisal University. She transitioned into Medical A airs in 2019 and now leads regional medical and scientific strategy across multiple therapeutic areas, including neurology, immunology, psychiatry, and rare diseases. Her work focuses on translating complex science into real-world clinical impact,strengthening medical excellence, and building high-performing, cross-functional teams. She also holds multiple executive and leadership certifications from leading global institutions,reflecting her continued commitment to innovation, digital transformation, and strategic leadership in healthcare. She is an active mentor and public speaker, passionate about advancing women leaders in healthcare and science, and driven by the belief that leadership is what transforms scientific possibility into meaningful impact.
We’d love to hear from you. Here’s how you can reach us.
General Inquiries
Forbes Middle East is a licensee of Forbes Media and extends the Forbes brand of journalism across the Arab world. Forbes Middle East’s distinctive editorial style attracts a readership of Arab leaders, entrepreneurs, C-level executives, government officials and investors united by a belief in the spirit of free enterprise and entrepreneurial values.Across the region, Forbes Middle East sets the pace for preemptive business journalism. By uncovering trends and anticipating opportunities in the regional marketplace, each monthly issue brings top executives the information critical to their success – in both Arabic and English language editions. The magazine researches and publishes original rankings, based on methodologies set by Forbes Media.